SE430601B - Analogiforfarande for framstellning av nya dipeptidderivat - Google Patents

Analogiforfarande for framstellning av nya dipeptidderivat

Info

Publication number
SE430601B
SE430601B SE7703283A SE7703283A SE430601B SE 430601 B SE430601 B SE 430601B SE 7703283 A SE7703283 A SE 7703283A SE 7703283 A SE7703283 A SE 7703283A SE 430601 B SE430601 B SE 430601B
Authority
SE
Sweden
Prior art keywords
preparing new
dipeptide derivatives
analogy procedure
new dipeptide
analogy
Prior art date
Application number
SE7703283A
Other languages
English (en)
Swedish (sv)
Other versions
SE7703283L (sv
Inventor
M Fujino
O Nishimura
Y Nagawa
N Fukuda
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of SE7703283L publication Critical patent/SE7703283L/xx
Publication of SE430601B publication Critical patent/SE430601B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/12—1,4-Thiazines; Hydrogenated 1,4-thiazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE7703283A 1976-03-23 1977-03-22 Analogiforfarande for framstellning av nya dipeptidderivat SE430601B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51032170A JPS5944308B2 (ja) 1976-03-23 1976-03-23 ペプタイド

Publications (2)

Publication Number Publication Date
SE7703283L SE7703283L (sv) 1977-09-24
SE430601B true SE430601B (sv) 1983-11-28

Family

ID=12351453

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7703283A SE430601B (sv) 1976-03-23 1977-03-22 Analogiforfarande for framstellning av nya dipeptidderivat

Country Status (19)

Country Link
US (1) US4100152A (fr)
JP (1) JPS5944308B2 (fr)
AT (1) AT360674B (fr)
AU (1) AU508387B2 (fr)
BE (1) BE852740A (fr)
CA (1) CA1060435A (fr)
CH (1) CH634548A5 (fr)
DE (1) DE2712086C2 (fr)
DK (1) DK149111C (fr)
FR (1) FR2345448A1 (fr)
GB (1) GB1579264A (fr)
GR (1) GR62565B (fr)
HK (1) HK27584A (fr)
HU (1) HU177515B (fr)
MY (1) MY8500264A (fr)
NL (1) NL188412C (fr)
SE (1) SE430601B (fr)
SG (1) SG76083G (fr)
ZA (1) ZA771495B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU180926B (en) * 1979-06-28 1983-05-30 Richter Gedeon Vegyeszet Process for preparing trh analogues,tripeptide amides infectives on the central nerve sysrhem
US4591648A (en) * 1981-04-01 1986-05-27 National Research Development Corp. Histidine protection
US4426378A (en) 1981-04-09 1984-01-17 The United States Of America As Represented By The Secretary Of The Army Thyrotropin releasing hormone in therapy of shock and as a central nervous system stimulant
JPS5849313A (ja) * 1981-09-16 1983-03-23 Takeda Chem Ind Ltd 抗てんかん剤
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
GB2146026A (en) * 1983-09-07 1985-04-11 Tanabe Seiyaku Co Peptides and process for preparing the same
JPS60190795A (ja) * 1984-03-09 1985-09-28 Takeda Chem Ind Ltd ペプタイド
US4608365A (en) * 1984-03-30 1986-08-26 University Of Southern California Treatment of neurologic functions
IL75641A (en) * 1984-07-10 1990-11-05 Tanabe Seiyaku Co 1-methyl-4,5-dihydro-orotyl-histidyl-prolinamide,its preparation and pharmaceutical compositions comprising it
GB2171101A (en) * 1985-02-20 1986-08-20 Tanabe Seiyaku Co Peptide and processes for preparation of the same
FR2585709B1 (fr) * 1985-08-05 1987-10-02 Adir Nouveaux derives peptidiques a structure lactonique ou cycloamidique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP2526589B2 (ja) * 1986-08-08 1996-08-21 武田薬品工業株式会社 ペプチド含有マイクロカプセルおよびその製造法
US5686420A (en) * 1987-06-05 1997-11-11 Georgetown University Thyrotropin-releasing hormone analogs and method of use
JPS63316724A (ja) * 1987-06-19 1988-12-26 Nippon Shinyaku Co Ltd 抗けいれん剤
US5151497A (en) * 1989-02-21 1992-09-29 Japan Tobacco Inc. Histidyl peptide derivatives
CA2050425A1 (fr) 1990-09-03 1992-03-04 Yoshiaki Uda Composition pharmaceutique et son utilisation avec du mucus
NZ240214A (en) 1990-10-16 1993-02-25 Takeda Chemical Industries Ltd Polymer compositions comprising a polylactic acid and a copolymer of glycolic acid and a hydroxycarboxylic acid; use as carrier for prolonged release pharmaceutical compositions of water soluble drugs
US5416071A (en) * 1991-03-12 1995-05-16 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release containing epo and hyaluronic acid
ATE161716T1 (de) 1992-08-07 1998-01-15 Takeda Chemical Industries Ltd Herstellung von mikrokapseln, die wasserlösliche arzneimittel enthalten
US6117455A (en) 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
US5837281A (en) 1995-03-17 1998-11-17 Takeda Chemical Industries, Ltd. Stabilized interface for iontophoresis
AU713030B2 (en) * 1995-10-24 1999-11-18 Gruenenthal Gmbh Method of adjusting the circadian rhythm of a mammal
CA2192782C (fr) 1995-12-15 2008-10-14 Nobuyuki Takechi Production de microsphere
CN1095681C (zh) * 1996-06-20 2002-12-11 久光制药株式会社 一种用于离子电渗疗法的装置结构
WO1998008867A1 (fr) * 1996-08-28 1998-03-05 Shionogi & Co., Ltd. Nouveaux derives de peptides presentant un residu de thiazolyle-alanine
US6410539B1 (en) * 1997-10-22 2002-06-25 Astrazenca Uk Limited Imidazole derivatives and their use as farnesyl protein transferase inhibitors
ATE205195T1 (de) 1997-10-22 2001-09-15 Astrazeneca Ab Imidazolderivate und ihre verwendung als farnesylproteintransferase inhibitoren
CA2403686C (fr) * 2000-03-23 2010-01-26 Merck & Co., Inc. Piperidines substituees en tant qu'agonistes du recepteur de la melanocortine
TWI285110B (en) * 2000-08-31 2007-08-11 Shionogi & Co Parkinson disease therapeutic agent
WO2002043709A1 (fr) 2000-12-01 2002-06-06 Takeda Chemical Industries, Ltd. Procede de production d'une preparation contenant une substance bioactive
GB0326632D0 (en) 2003-11-14 2003-12-17 Jagotec Ag Dry powder formulations
US20130177651A1 (en) 2010-09-03 2013-07-11 Pharmaterials Limited Pharmaceutical Composition Suitable for Use in a Dry Powder Inhaler
US20150157619A1 (en) 2012-07-10 2015-06-11 Takeda Pharmaceutical Company Limited Pharmaceutical preparation for injection
KR20240055783A (ko) 2021-09-09 2024-04-29 쇼 인더스트리즈 그룹, 인코포레이티드 기재에 인쇄하기 위한 방법 및 디바이스

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3753969A (en) * 1969-12-22 1973-08-21 K Folkers Method for synthesizing pyroglutamylhistidyl-prolinamide
US3821188A (en) * 1972-06-14 1974-06-28 American Home Prod Proline and pyroglutamic acid containing tripeptides
US3959248A (en) * 1974-04-03 1976-05-25 Merck & Co., Inc. Analogs of thyrotropin-releasing hormone
DE2449167C2 (de) * 1974-10-16 1984-05-24 Grünenthal GmbH, 5190 Stolberg N-Acyl-L-histidyl-L-prolinamide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
HK27584A (en) 1984-03-30
NL188412B (nl) 1992-01-16
JPS5944308B2 (ja) 1984-10-29
HU177515B (en) 1981-10-28
AU2354977A (en) 1978-09-28
DE2712086A1 (de) 1977-09-29
MY8500264A (en) 1985-12-31
DK149111B (da) 1986-01-27
GR62565B (en) 1979-05-10
SE7703283L (sv) 1977-09-24
DE2712086C2 (de) 1986-04-03
AT360674B (de) 1981-01-26
US4100152A (en) 1978-07-11
FR2345448A1 (fr) 1977-10-21
SG76083G (en) 1984-08-03
AU508387B2 (en) 1980-03-20
JPS52116465A (en) 1977-09-29
NL7703115A (nl) 1977-09-27
ATA202377A (de) 1980-06-15
BE852740A (fr) 1977-07-18
FR2345448B1 (fr) 1980-06-27
ZA771495B (en) 1978-02-22
CH634548A5 (de) 1983-02-15
DK149111C (da) 1986-06-09
GB1579264A (en) 1980-11-19
CA1060435A (fr) 1979-08-14
NL188412C (nl) 1992-06-16
DK119577A (da) 1977-09-24

Similar Documents

Publication Publication Date Title
SE442400B (sv) Forfarande for framstellning av nya 1-aryloxi-2-hydroxi-3-alkylenaminopropaner
SE446740B (sv) Forfarande for framstellning av muramyldipeptidderivat
SE440772B (sv) Forfarande for framstellning av nya 1-naftylmetyl-cinnamyl-aminderivat
SE434057B (sv) Forfarande for framstellning av nya rifamycinforeningar
SE432595B (sv) Analogiforfarande for framstellning av piperidyl-indolderivat
SE437515B (sv) Forfarande for framstellning av nya fenyletylaminer
SE420314B (sv) Analogiforfarande for framstellning av indolizinderivat
SE438856B (sv) Analogiforfarande for framstellning av 1-acyloximetyl-3-fluoruracilderivat
SE428684B (sv) Analogiforfarande for framstellning av substituerade (3-lagalkylamino-2-hydroxi-propoxi)pyridiner
SE7704545L (sv) Forfarande for framstellning av nya adeninderivat
DK283177A (da) Fremgangsmade til fremstilling af dipeptidderivater
SE433745B (sv) Forfarande for framstellning av tetrahydroisokinolinderivat
SE433212B (sv) Forfarande for framstellning av 4-hydroxi-aporfin-derivat
SE436566B (sv) Analogiforfarande for framstellning av nya fenetylaminderivat
SE423390B (sv) Foerfarande foer framstaellning av eburnameninderivat
SE428685B (sv) Analogiforfarande for framstellning av cyanosubstituerade (3-lagalkylamino-2-acyl-0-propoxi)pyridiner
SE424553B (sv) Forfarande for framstellning av nya indazol-derivat
SE428296B (sv) Analogiforfarande for framstellning av substituerade difonylsulfider
SE433220B (sv) Forfarande for framstellning av nya pregnan-derivat
SE7614264L (sv) Forfarande for framstellning av nya 17-estrar av 17alfa-hydroxigestogener
SE443140B (sv) Forfarande for framstellning av karbostyrilderivat
SE7703634L (sv) Forfarande for framstellning av nya amidinopenicillanoyloxialkylamoxicillinater
SE431539B (sv) Analogiforfaranden for framstellning av nya bensylalkoholderivat
SE431336B (sv) Analogiforfarande for framstellning av substituerade 8-azapurinderivat
SE440903B (sv) Forfarande for framstellning av nya 1-aryloxi-2-hydroxi-3-aminopropaner

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7703283-7

Effective date: 19941010

Format of ref document f/p: F